Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06416150 · ClinicalTrials.gov registry record · NA
Reducing Urban Cervical Cancer Disparities
A NA study of Cervical Cancer and Papilloma Viral Infection, sponsored by Fox Chase Cancer Center.
- Recruiting
- Registry status
- NA
- Development phase
- 546
- Enrollment target
- 3
- Study locations
NCT06416150 is a NA study of Cervical Cancer and Papilloma Viral Infection that is actively recruiting participants, run by Fox Chase Cancer Center. The registered enrollment target is 546 participants, roughly in line with the 567-participant average among 144 other Cervical Cancer trials with a reported enrollment target. The trial reports 3 study locations across 2 states.
The verdict
NCT06416150, a NA study of Cervical Cancer and Papilloma Viral Infection, is actively recruiting participants, sponsored by Fox Chase Cancer Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 546 participants
- Enrollment target
- 3
- Study locations
Study Summary
This study uses a hybrid Type 1 effectiveness-implementation trial to operationalize and assess the efficacy of the Health Enhancement Resource System (HERS) intervention. HERS aims to increase patient follow-up after abnormal test results through text message-based barriers counseling for women and supplemental telephone-based Health Coaching for women who miss their appointment.
Conditions Studied
Interventions
- BEHAVIORAL Stage 1 SOC
- BEHAVIORAL Stage 1 HERS
- BEHAVIORAL Stage 2 HERS
- BEHAVIORAL Stage 2 HERS+HC
- BEHAVIORAL Stage 3 SOC
Study Locations (3)
Pennsylvania
- Thomas Jefferson University - Philadelphia
- Fox Chase Cancer Center - Philadelphia
New Jersey
- Rutgers, The State University of New Jersey - New Brunswick
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 546 participants |
| Start Date | 2024-08-28 |
| Est. Completion | 2027-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06416150
The ClinicalTrials.gov registry entry for NCT06416150 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 546 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 567-participant average among 144 other Cervical Cancer trials with a reported enrollment target. The listed sponsor is Fox Chase Cancer Center, which has 183 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Cervical Cancer appearing as the primary indexed condition, and to 5 interventions - of which Stage 1 SOC is the first listed.
NCT06416150 reports 3 study locations spanning 2 distinct geographic areas - top geographies include Pennsylvania, New Jersey.
Frequently Asked Questions
What is clinical trial NCT06416150 about?
NCT06416150 is a clinical study titled "Reducing Urban Cervical Cancer Disparities". This study uses a hybrid Type 1 effectiveness-implementation trial to operationalize and assess the efficacy of the Health Enhancement Resource System (HERS) intervention. HERS aims to increase patient follow-up after abnormal test results through text message-based barriers counseling for women and...
What is the current status of trial NCT06416150?
This trial is currently recruiting. It is a NA study. The enrollment target is 546 participants. The study started on 2024-08-28. Estimated completion is 2027-12.
What conditions does trial NCT06416150 study?
This clinical trial studies the following conditions: Cervical Cancer, Papilloma Viral Infection.
What interventions are being tested in trial NCT06416150?
The interventions under investigation include: Stage 1 SOC (BEHAVIORAL), Stage 1 HERS (BEHAVIORAL), Stage 2 HERS (BEHAVIORAL), Stage 2 HERS+HC (BEHAVIORAL), Stage 3 SOC (BEHAVIORAL).
Who is sponsoring clinical trial NCT06416150?
This trial is sponsored by Fox Chase Cancer Center, which has 183 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06416150 being conducted?
This trial has 3 study locations across New Jersey, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cervical Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
PopSci CHW4CervixHealth
RECRUITING · NA
-
ASk Questions in GYnecologic Oncology (ASQ-GYO)
RECRUITING · NA
-
ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services
RECRUITING · NA
-
Improving Care for Rural Patients With Solid Tumors
RECRUITING · NA
-
Self-Collection of the Pap Smear as Agency: A Novel Way to Improve Refractory Low Cervical Cancer Screening Rates in Rural Alabama
RECRUITING · NA
-
Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment)
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.